Patents/Assignees

Stemline Therapeutics, Inc.

4 patents in portfolio

US12357678utility2025
Cancer Stem Cell Targeted Cancer Vaccines
0 cites
US12357700utility2025
Combination Therapy Method of Treating Myeloproliferative Neoplasms with a Diphtheria Toxin-human Interleukin-3 Conjugate in Combination with Other Agents
0 cites
US12187802utility2025
Il3ralpha Antibodies and Uses Thereof
0 cites
US11672847utility2023
Cancer Stem Cell Targeted Cancer Vaccines
0 cites